Gender‐affirming hormone therapy and the risk of sex hormone‐dependent tumours in transgender individuals—A systematic review

@article{McFarlane2018GenderaffirmingHT,
  title={Gender‐affirming hormone therapy and the risk of sex hormone‐dependent tumours in transgender individuals—A systematic review},
  author={Thomas McFarlane and J. Zajac and A. Cheung},
  journal={Clinical Endocrinology},
  year={2018},
  volume={89},
  pages={700 - 711}
}
Cancers are a leading cause of death worldwide, and transgender individuals are no exception. The effects of gender‐affirming hormone therapy (GAHT) on sex hormone‐dependent tumours are unclear. Therefore, this review seeks to determine whether tumour risk in transgender individuals differs from the general population, to guide clinical screening recommendations. 
View on Wolters Kluwer
onlinelibrary.wiley.com
14 Citations
Background Citations
4

14 Citations

Citation Type

Citation Type

Position statement on the hormonal management of adult transgender and gender diverse individuals
Testosterone therapy considerations in estrogen, progesterone and androgen receptor positive breast cancer in a transgender male.
Effects of antiandrogens on prolactin levels among transgender women on estrogen therapy: A systematic review
Health considerations for transgender women and remaining unknowns: a narrative review
Inclusion of transgender and gender diverse health data in cancer biorepositories
Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals
Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model.
Gender affirming medical care of transgender youth.
Biomedical issues in transgender health research
Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment
...
1
2
...

References

SHOWING 1-10 OF 75 REFERENCES
Triple negative breast cancer in a male‐to‐female transsexual
Mortality and morbidity in transsexual subjects treated with cross‐sex hormones
The Development of Prostate Adenocarcinoma in a Transgender Male to Female Patient: Could Estrogen Therapy Have Played a Role?
Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management.
Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy.
Breast cancer in male-to-female (MtF) transgender patients: is hormone receptor negativity a feature?
Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones.
Five new cases of breast cancer in transsexual persons
Breast cancer development in transsexual subjects receiving cross-sex hormone treatment.
Recurrence and Progression of Meningioma in Male-to-Female Transgender Individuals During Exogenous Hormone Use
...
1
2
3
4
5
...